Skip to main content
Erschienen in: BMC Pediatrics 1/2024

Open Access 01.12.2024 | Research

Changes in the epidemiology and clinical characteristics of viral gastroenteritis among hospitalized children in the Mainland of China: a retrospective study from 2016 to 2020

verfasst von: Fei Li, Lingyun Guo, Qi Li, Hui Xu, Yiliang Fu, Luci Huang, Guoshuang Feng, Gang Liu, Xiangpeng Chen, Zhengde Xie

Erschienen in: BMC Pediatrics | Ausgabe 1/2024

Abstract

Background

Acute gastroenteritis (AGE) causes significant morbidity in children worldwide; however, the disease burden of children hospitalized with viral gastroenteritis in China has been rarely described. Through this study, we analyzed the data of hospitalized children with viral gastroenteritis to explore the changes in the epidemiology and clinical characteristics of viral gastroenteritis in the mainland of China.

Methods

Data were extracted from Futang Children's Medical Development Research Center (FRCPD), between 2016 and 2020, across 27 hospitals in 7 regions. The demographics, geographic distribution, pathogenic examination results, complications, hospital admission date, length of hospital stays, hospitalization charges and outcomes were collected and analyzed.

Results

Viral etiological agents included rotavirus (RV), adenovirus (ADV), norovirus (NV) and coxsackievirus (CV) that were detected in 25,274 (89.6%), 1,047 (3.7%), 441 (1.5%) and 83 (0.3%) cases. There was a higher prevalence of RV and NV infection among children younger than 3 years of age. RV and NV had the highest detection rates in winter, while ADV in summer. Children with viral gastroenteritis were often accompanied by other diseases, such as myocardial diseases (10.98–31.04%), upper respiratory tract diseases (1.20–20.15%), and seizures (2.41–14.51%). Among those cases, the co-infection rate with other pathogens was 6.28%, with Mycoplasma pneumoniae (M. pneumoniae), Epstein-Barr virus (EBV), and influenza virus (FLU) being the most common pathogens. The median length of stay was 5 days, and the median cost of hospitalization corresponded to587 US dollars.

Conclusions

This finding suggests that viral gastroenteritis, especially those caused by RV, is a prevalent illness among younger children. Co-infections and the presence of other diseases are common. The seasonality and regional variation of viral etiological agents highlight the need for targeted prevention and control measures. Although viral gastroenteritis rarely leads to death, it also results in a significant economic burden on healthcare systems.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12887-024-04776-1.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AGE
Acute gastroenteritis
FRCPD
Futang Children's Medical Development Research Center
RV
Rotavirus
NV
Norovirus
ADV
Adenovirus
CV
Coxsackievirus
EV
Enterovirus
M. pneumoniae
Mycoplasma pneumoniae
EBV
Epstein-Barr virus
FLU
Influenza virus
AV
Astrovirus
NIPs
National Immunization Programs
FSMRs
Face sheet of discharge medical records
ICD-10
International Statistical Classification of Diseases and Related Health Problems 10th Revision
IQR
Interquartile range
CMV
Cytomegalovirus
C. albicans
Candidaalbicans
RSV
Respiratory syncytial virus
LOS
Length of stay
WHO
World Health Organization
LLR
Lanzhou lamb rotavirus
RV5
RotaTeq
LLR3
Lanzhou lamb reassortant rotavirus vaccine, live, oral, trivalent (Vero cell)
RVGE
Rotavirus gastroenteritis
CNS
Central nervous system

Background

Acute gastroenteritis is a common disease that affects people of all ages, leading to serious complications in young children and the elderly [14]. In China, infectious diarrhea (excluding cholera, dysentery and enteric fever) has been classified as a class C infectious disease according to the national notifiable infectious diseases reporting system. Enteric viral pathogens are gradually becoming the leading pathogens of gastroenteritis which is also known as infectious diarrhea, due to the improved the quality of drinking water and the frequent use of antibiotics. Clinical manifestations of viral gastroenteritis include fever, abdominal pain, watery diarrhea, nausea and vomiting. Viral gastroenteritis is usually a self-limiting illness, requiring mainly supportive therapy, which usually resolves within 2–5 days. Viral pathogens include rotavirus (RV), norovirus (NV), astrovirus (AV) and adenovirus (ADV). NV infection affects people of all ages, while RV mainly infects children, particularly those under five years of age [58].
The implementation of RV vaccination has reduced RV problems to some extent, but the contribution of RV to pediatric acute gastroenteritis has not been replaced by other pathogens [3, 6, 9]. Vaccination has helped to reduce RV hospitalization, as well as change the epidemiology of RV disease in the United States and Spain [10, 11]. RV vaccine is part of the National Immunization Programs (NIPs) in many countries, but it has not been included in China’s NIPs. The epidemiology and distribution of common pathogens causing infectious gastroenteritis, particularly viruses, are unclear in developing countries including China.
In China, there are few multicenter studies on the clinical epidemiological characteristics and disease burden of viral gastroenteritis in children. By using the hospitals’ electronic medical record management system, the medical data generated during the hospitalization of patients can be summarized into face sheet of discharge medical records (FSMRs). This study aimed to summarize and provide relevant data on the clinical epidemiology and disease burden of viral gastroenteritis in hospitalized children in China.

Methods

Study design and participants

In China, Futang Children's Medical Development Research Center (FRCPD) is the first non-profit social service organization established to care for children's lives and health and engage in children’s development research [12], supervised and managed by the Ministry of Civil Affairs of the People’s Republic of China and led by the Children’s Medical Center. The center currently consists of 47 provincial and municipal medical institutions and has established a nationwide children health service network [13]. In Dec 2015, FRCPD began to collect the data of FSMRs from its member hospitals. The National Center for Children's Health (Beijing), Beijing Children’s Hospital, Capital Medical University collected the data of the hospitalized children’s medical records from Jan 1st, 2016 to Dec 31st, 2020 in 27 tertiary children's hospitals under the FRCDP (Supplementary Material 1).
We designed this study to collect basic medical information of children hospitalized with viral gastroenteritis in the FUTang Updating medical REcords (FUTURE) database from 2016 to 2020, and extracted relevant information from the system based on the tenth revision of the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) code for children diagnosed with viral gastroenteritis (Fig. 1). The demographic information isdisplayed in Table 1. Subgroups were divided according to the sex, age, region, and time of hospitalization status. All hospitals were divided into seven geographic regions. According to different ages, hospitalized children with viral gastroenteritis were divided into six groups, including neonate (≤ 28 days), infant (28 days <  ~  ≤ 1 year old, neonate were excluded), toddler (1 <  ~  ≤ 3 years old), preschooler (3 <  ~  ≤ 6 years old), school–age children (6 <  ~  ≤ 12 years old), adolescence (12 <  ~  < 18 years old).
Table 1
Demographics across cohort of patients with confirmation of viral gastroenteritis. Values are positive numbers (rate) unless stated otherwise
Characteristic
Patients (n)
Patients with viral gastroenteritis (n, %)
χ2
P value
Total
5,711,724
28,189(0.49)
  
Sex
  
16.863
< 0.001
 Male
3,532,336
17,099 (0.48)
  
 Female
2,179,388
11,090 (0.51)
  
Age group
  
23,590.088
< 0.001
 ≤ 28 days
571,879
733 (0.13)
  
 28 days <  ~  ≤ 1 years old
1,632,150
17,563 (1.08)
  
 1 <  ~  ≤ 3 years old
1,207,254
8803 (0.73)
  
 3 <  ~  ≤ 6 years old
1,099,157
959 (0.09)
  
 6 <  ~  ≤ 12 years old
1,030,936
124 (0.01)
  
  > 12 years old
170,348
7 (0.00)
  
Years
  
331.482
< 0.001
 2016
1,015,850
5102 (0.50)a
  
 2017
1,123,239
6618 (0.59)
  
 2018
1,205,364
5919 (0.49)a
  
 2019
1,337,314
6129 (0.46)
  
 2020
1,029,957
4421 (0.43)
  
Seasons
  
11,117.324
< 0.001
 Spring
1,362,478
6090(0.45)
  
 Summer
1,525,852
2731(0.18)
  
 Autumn
1,412,944
5188(0.37)
  
 Winter
1,410,450
14,180(1.01)
  
Regions
  
9,236.243
< 0.001
 Northeast China
249,244
2023(0.81)
  
 North China
828,006
3020(0.36)a
  
 East China
1,896,173
6960(0.37)a
  
 South China
422,268
1689(0.40)
  
 Central China
1,098,999
2671(0.24)
  
 Northwest China
775,561
8505(1.10)
  
 Southwest China
441,473
3321(0.75)
  
Hospital discharge-dollars
 
-
 Discharge against medical advice
1640 (5.82)
  
 Other
174 (0.62)
  
 Discharge with medical advice
26,363 (93.52)
  
 Transferred to other hospital with medical advice
12 (0.04)
  
 Death
0(0.00)
  
Hospitalization
 
-
 Length of stay- days
  
 Median
 
5
  
 Interquartile range
 
3–6
  
Cost-US dollars
 Median
 
587
  
 Interquartile range
 
541–642
  
Letters “a” showed that there was not different between these groups

Inclusion and exclusion criteria

This retrospective study included only children under the age of 18 who were hospitalized for viral gastroenteritis based on the classification of viral gastroenteritis according to ICD-10 codes, we collected basic medical information from the FUTURE database. Children were diagnosed with viral gastroenteritis according to the clinical and etiological diagnosis [3, 4]. Data of children with unknown sex, age, region or resident condition were excluded.

Statistical analysis

Continuous variables were presented as mean ± standard deviation (SD) and compared between groups by Student’s t-test when normally distributed. For not normally distributed variables, the data were expressed as median (interquartile range, IQR), and Kruskal–Wallis test as well as Steel–Dwass test (for multiple comparisons) were performed to compare the difference among groups. Categorical variables were expressed as number (%) or proportions and compared between/among groups by χ2 or Fisher’s exact tests, when appropriate. IBM SPSS Statistics 23.0 software (SPSS Inc., USA) was used for data analysis. P value < 0.05 was considered statistically significant.

Results

Prevalence of viral gastroenteritis in children

During 2016–2020, a total of 28,189 hospitalized children with viral gastroenteritis were enrolled in the FUTang Updating medical Records (FUTURE) database, which accounted for 0.5% (28,189/5,711,724) of all hospitalized cases, with 60.6% male (17,099) and 39.3% female (11,096) (Table 1). In different month and admission years, the proportions of male were higher compared to female (Fig. 2). The information on sex, age, year, season, regions and outcomes is shown in Table 1.
In different genders, years, regions, and age groups, we evaluated the proportion of viral gastroenteritis hospitalizations to total hospitalization (Table 1, Fig. 2). Females had a higher proportion of children with viral gastroenteritis than males (P < 0.001), with the rates of 0.5% (11,090/2,179,388) and 0.5% (17,099/3,532,336), respectively (Table 1). The rate of viral gastroenteritis in the age group from 29 days to 1 year old was significantly higher than those in other age groups (Table 1) (P < 0.001). The proportion of viral gastroenteritis hospitalizations to total hospitalization also differed with seasonal variability, which was higher in winter and lower in summer (Table 1) (P < 0.001). Northwest China had the highest proportion (1.1%, 8,505/775,561) and Central China had the lowest proportion (0.2%, 2,671/1,098,999) (P < 0.001).

Viral gastroenteritis characterized by different viral pathogens

Among those admitted to the hospital with a diagnosis of viral gastroenteritis, 95.2% (26,845/28,189) cases were positive for viral infection (RV, NV, CV and ADV) (Table 2, Fig. 3). RV had the highest positive proportion (89.7%) than the other viruses (P < 0.001). RV, NV, CV and ADV had the highest positive rate in the 28 days <  ~  ≤ 1 year group than other age groups (P < 0.001). RV and NV had the highest detection rate in winter compared with other seasons, while ADV had the highest detection rate in summer (P < 0.001). RV showed high detection rates in Northwest China and East China (28.3% and 25.4%), while NV had a high detection rate in North China, CV in East China and ADV in Northwest China (46.9%, 94.0% and 61.5%) compared to other regions (P < 0.001) (Table 2).
Table 2
Positive number(n) and rate (%) of children hospitalized for viral gastroenteritis from 2016 to 2020
Characteristic
CV
RV
NV
ADV
Not clear
Total (n = 28,189)
83(0.29)
25,274(89.66)
441(1.56)
1047(3.71)
1344(4.77)
P value
  
<0.001
  
Sex
 Male(n = 17,099)
51(61.45)
15,395(60.91)
262(59.41)
615(58.74)
776(57.74)
 Female(n = 11,090)
32(38.55)
9879(30.09)
179(40.59)
432(41.26)
568(42.26)
 χ2
0.022
6.607
0.292
1.678
5.044
 P value
0.883
0.010
0.589
0.195
0.025
Age group
 ≤ 28 days(n = 733)
9(10.84)a
677(2.68)a
8(1.81)a
13(1.24)a
26 (1.93)a,b
 28 days <  ~  ≤ 1 years old(n = 17,563)
47(56.63)b
15,635(61.86)
249(56.46)a
764 (72.97)b,c
868(64.58)b
 1 <  ~  ≤ 3 years old(n = 8803)
26(31.33)b
8034(31.79)a
142 (32.20)a
234(22.35)a,d,e
367(27.31)a
 3 <  ~  ≤ 6 years old(n = 959)
1 (1.20)b
831(3.29)
32(7.26)b
33(3.15)b,c,d,e
62(4.61)c
 6 <  ~  ≤ 12 years old(n = 124)
0(0.00) a,b
93(0.37)b
9(2.04)c
2(0.19)a,c,e
20(1.49)d
 > 12 years old(n = 7)
0(0.00) a,b
4(0.02)b
1(0.23)b,c
1(0.10)b,d
1(0.07)a,b,c,d
 χ2
23.752
83.984
56.675
58.943
53.265
 P value
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
Years
 2016(n = 5102)
23(27.71)a
4754 (18.81)
3(0.68)a
120(11.46)a
202 (15.03)
 2017(n = 6618)
45(54.22)a
6267(24.80)
12(2.72)a
143(13.66)a
151(11.24)
 2018(n = 5919)
11(13.25)
5319(21.05)
33(7.48)
252(24.07)b
304(22.62)a
 2019(n = 6129)
3(3.61)b
5292(20.94)
117(26.53)
271(25.88)b
446(33.18)
 2020(n = 4421)
1(1.20)b
3642(14.41)
276(62.59)
261(24.93)
241 (17.93)a
 χ2
63.841
574.912
829.389
143.848
188.731
 P value
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
Seasons
 Spring(n = 6090)
19(22.89)
5508(21.79)
56(12.70)
189(18.05)
318(23.66)a
 Summer(n = 2731)
10(12.05)
2028(8.02)
54(12.24)
356(34.00)
283(21.06)
 Autumn(n = 5188)
18(21.69)
4380(17.33)
152(34.47)
346(33.05)
292(21.73)a
 Winter(n = 14,180)
36(43.37)
13,358(52.85)
179(40.59)
156(14.90)
451(33.56)
 χ2
1.824
1171.716
90.68
1067.481
278.173
 P value
0.610
< 0.001
< 0.001
< 0.001
< 0.001
Regions
 Northeast China(n = 2023)
0(0.00)a,b,c,d,e
1939(7.67)a
47(10.66)a
0(0.00)
37(2.75)a
 North China(n = 3020)
0(0.001)d,e
2418(9.57)
207(46.94)
122(11.65)
273(20.31)b
 East China(n = 6960)
78(93.98)
6428(25.43)c
40(9.07)
182(17.38)a
232(17.26)
 South China(n = 1689)
1(1.20)b,c,e
1560(6.17)c
68(15.42)
25(2.39)b
35(2.60)a
 Central China(n = 2671)
4(4.82)c
2583(10.22)a
4(0.91)b
53(5.06)a,b
27 (2.01)
 Northwest China(n = 8505)
0(0.00)a,d
7156(28.31)
19(4.31)b
644(61.51)
686(51.04)b
 Southwest China(n = 3321)
0(0.00)a,b,d,e
3190(12.62)a
56(12.70)a
21(2.01)
54(4.02)a
 χ2
216.754
1020.363
801.414
590.509
577.404
 P value
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
Hospital discharge, n (proportion, %)
 Against medical advice(n = 1640)
4(4.82)
1461(5.78)
44(9.98)
52(4.97)
79(5.88)
 Other(n = 174)
2(2.41)
165(0.65)
0(0.00)
3(0.29)
4(0.30)
 With medical advice(n = 26,363)
77(92.77)
23,637(93.52)
397(90.02)
992(94.75)
1260(93.75)
 Transferred to other hospital(n = 12)
0(0.00)
11(0.04)
0(0.00)
0(0.00)
1(0.07)
Letters “a” “b” “c” “d” and “e” showed that there was different between groups in the different groups
CV Coxsackievirus, RV Rotavirus, NV Norovirus, ADV Adenovirus

Viral gastroenteritis combined with other diseases

Children hospitalized with viral gastroenteritis were often presented with one or more coexisting diseases. Among the 25,274 cases of RV-positive children, they had various other diseases. Specifically, 31.04% had myocardial diseases, 14.41% had upper respiratory tract diseases, 11.83% had bronchitis, and 6.92% had bronchopneumonia. Meantime, myocardial diseases and upper respiratory tract diseases are also common in children infected with CV, NV and ADV (Table 3). Among positive cases of CV (23 cases), RV (7845 cases), NV (75 cases), and ADV (115 cases) with myocardial diseases, myocardial injury rates were highest for cases of myocardial impairment, with 100.00% (23 cases), 78.88% (6188 cases), 95.0% (72 cases), and 73.04% (84 cases), respectively. Nervous system diseases such as seizure accounted for 14.51% of children with NV, 6.02% with ADV, 5.60% with RV and 2.41% with CV. Among RV-positive children with seizures, there were 14 cases of febrile seizures (0.99%), 31 cases of benign convulsions with gastroenteritis (2.19%), and 218 cases of benign infantile convulsions (15.41%). Moreover, other diseases were relatively low, such as urogenital diseases, and nutritional diseases (Table 3).
Table 3
Positive number(n) and rate (%) of children hospitalized for viral gastroenteritis with different diseases
Diseases
CV (n = 83)
RV (n = 25,274)
NV (n = 441)
ADV (n = 1047)
Respiratory diseases
 Upper respiratory tract diseases
1 (1.20)
3641 (14.41)
86 (19.50)
211 (20.15)
 Bronchitis
3 (3.61)
2991 (11.83)
48 (10.88)
100 (9.55)
 Bronchopneumonia
0 (0)
1748 (6.92)
28 (6.35)
40 (3.82)
 Pneumonia
2 (2.41)
1102 (4.36)
17 (3.85)
29 (2.77)
 Asthma
0 (0)
26 (0.10)
0 (0)
0 (0)
 Respiratory failure
0 (0)
28 (0.11)
0 (0)
3 (0.29)
 Pulmonary vascular diseasea
0 (0)
24 (0.09)
0 (0)
3 (0.29)
Urogenital diseases
 Hematuria and/or Proteinuria
0 (0)
5 (0.02)
0 (0)
0 (0)
 Nephritis
0 (0)
5 (0.02)
0 (0)
0 (0)
 Renal failure
0 (0)
93 (0.37)
0 (0)
1 (0.10)
 Renal insufficiency
0 (0)
162 (0.64)
2 (0.45)
3 (0.29)
 Nephrotic syndrome
0 (0)
12 (0.05)
0 (0)
0 (0)
 Urethral diseasesa
0 (0)
14 (0.06)
0 (0)
0 (0)
 Urethral stone, obstruction and hydroureter
0 (0)
44 (0.17)
0 (0)
5 (0.48)
Endocrine system diseases
 Abnormal glucose metabolism
0 (0)
291 (1.15)
11 (2.49)
26 (2.48)
 Diabetes
0 (0)
10 (0.04)
0 (0)
0 (0)
 Obesity
0 (0)
1 (0.004)
0 (0)
0 (0)
 Hyperinsulinemia
0 (0)
1 (0.004)
0 (0)
0 (0)
 Pancreatitis
0 (0)
5 (0.02)
0 (0)
0 (0)
 Thyroid function abnormalities
0 (0)
206 (0.82)
9 (2.04)
2 (0.19)
 Rickets
0 (0)
9 (0.04)
0 (0)
0 (0)
Immune system diseases
 Kawasaki disease
0 (0)
22 (0.09)
2 (0.45)
1 (0.10)
 Hypogammaglobulinemia
0 (0)
21 (0.08)
0 (0)
0 (0)
 Antibody deficiency disorders
0 (0)
1 (0.004)
0 (0)
0 (0)
 Immunoglobulin deficiency syndromes
0 (0)
49 (0.19)
1 (0.23)
0 (0)
 Skin and subcutaneous tissue diseasesa
2 (2.41)
739 (2.92)
13 (2.95)
25 (2.39)
Nervous system diseases
 Epilepsy
0 (0)
327 (1.29)
5 (1.13)
12 (1.15)
 Seizureb
2 (2.41)
1415 (5.60)
64 (14.51)
63 (6.02)
 Febrile seizures
0 (0)
14 (0.99)
2 (6.25)
0 (0)
 Benign convulsions with gastroenteritis
0 (0)
31 (2.19)
7 (21.88)
3 (7.14)
 Benign infantile convulsions
0 (0)
218 (15.41)
23 (71.88)
18 (42.86)
 Congenital diseasea
4 (4.82)
426 (1.69)
9 (2.04)
8 (0.76)
Digestive system diseases
 Digestive tract stenosis and obstruction
0 (0)
444 (1.76)
8 (1.81)
13 (1.24)
 Gastrointestinal hemorrhage
0 (0)
140 (0.55)
1 (0.23)
5 (0.48)
 Biliary tract or bile duct diseases
0 (0)
25 (0.10)
1 (0.23)
4 (0.38)
 cholestasis
0 (0)
19 (0.08)
1 (0.23)
4 (0.38)
 Hepatic failure
0 (0)
16 (0.06)
0 (0)
1 (0.10)
 Hepatic dysfunction
5 (6.02)
1556 (6.16)
17 (3.85)
25 (2.39)
 Other liver-related diseasesa
0 (0)
240 (0.95)
6 (1.36)
10 (0.96)
 Peptic ulcer
0 (0)
51 (0.20)
1 (0.23)
0 (0)
 Neonatal diseasesa
1 (1.20)
578 (2.29)
9 (2.04)
24 (2.29)
Hematologic diseases
 Leukocyte-related disorders
0 (0)
141 (0.56)
4 (0.91)
2 (0.19)
 Neutrophilic diseases
4 (4.82)
1220 (4.83)
23 (5.22)
32 (3.06)
 Platelet disorders
0 (0)
104 (0.41)
4 (0.91)
6 (0.57)
 Hemolytic anemia
0 (0)
1 (0.004)
1 (0.23)
0 (0)
 Nutritional anemia
1 (1.20)
448 (1.77)
5 (1.13)
36 (3.44)
 Aplastic anemia
0 (0)
3 (0.01)
1 (0.23)
1 (0.10)
 Thalassemia
0 (0)
19 (0.08)
0 (0)
0 (0)
 Coagulation disorders
0 (0)
34 (0.13)
2 (0.45)
3 (0.29)
 Favism
0 (0)
20 (0.08)
1 (0.23)
0 (0)
 Langerhans cell histiocytosis
0 (0)
3 (0.01)
0 (0)
0 (0)
 Hemophagocytic syndrome
0 (0)
4 (0.02)
1 (0.23)
0 (0)
 Lymphadenoma
0 (0)
5 (0.02)
0 (0)
0 (0)
 Leukemia
0 (0)
12 (0.05)
0 (0)
0 (0)
Circulatory system diseases
 Congenital heart disease
0 (0)
1186 (4.69)
13 (2.95)
65 (6.21)
 Cardiac insufficiency
0 (0)
13 (0.05)
1 (0.23)
1 (0.10)
 Myocardial diseasesb
23 (27.71)
7845 (31.04)
75 (17.01)
115 (10.98)
 Abnormal cardiac enzymes
0 (0)
261 (3.33)
2 (2.67)
0 (0)
 Myocardial impairment
23 (100)
6188 (78.88)
72 (96.00)
84 (73.04)
 Myocarditis
0 (0)
22 (0.28)
0 (0)
2 (1.74)
 Cardiomyopathy
0 (0)
11(0.14)
0 (0)
1 (0.87)
 Heart failure
0 (0)
8 (0.03)
0 (0)
2 (0.19)
 Arrhythmia
2 (2.41)
95 (0.38)
0 (0)
3 (0.29)
 Valvar heart diseases
0 (0)
20 (0.08)
0 (0)
0 (0)
 Primary structural cardiac anomalies
0 (0)
7 (0.03)
0 (0)
1 (0.10)
 Cardio vascular diseases
0 (0)
19 (0.08)
1 (0.23)
0 (0)
 Hereditary diseases
0 (0)
31 (0.12)
2 (0.45)
0 (0)
Nutritional diseases
 Growth retardation
1 (1.20)
114 (0.45)
3 (0.68)
4 (0.38)
 Vitamin deficiency
0 (0)
102 (0.40)
5 (1.13)
3 (0.29)
 Malnutrition
7 (8.43)
522 (2.07)
16 (3.63)
29 (2.77)
CV Coxsackievirus, RV Rotavirus, NV Norovirus, ADV Adenovirus
aPulmonary vascular disease: pulmonary artery stenosis, pulmonary valve stenosis, pulmonary artery fistula, etc. Urethral diseases: hypospadias, urethritis, urethral stricture, etc. Skin and subcutaneous tissue diseases: polymorphic rash, lymphadenopathy, etc. Congenital disease: trisomy 21 syndrome, congenital malformation, imperforate anus, congenital rubella syndrome, congenital hyperinsulinism, etc. other liver-related diseases: glycogen storage disease, fatty liver, hepatoblastoma, cirrhosis, etc. Neonatal diseases: neonatal septicemia, neonatal hypothermia, Neonatal hyperbilirubinemia, neonatal encephalopathy, etc.
bNumbers in italics represent subcategories in Seizure and Myocardial diseases. A definition for each of the subcategories of seizures and cardiomyopathy was shown in Supplementary Material 2

Coinfection with other pathogens

 For 26,845 viral gastroenteritis cases with RV, CV, NV or ADV, the co-infection rate was 6.28% (1686/26845): viruses in 792 (2.95%), bacteria in 176 (0.66%), fungi and atypical pathogens in 718 (2.67%). The most commonly co-infection pathogens were Mycoplasma pneumoniae (M. pneumoniae) (1.95%, 523 cases), Epstein-Barr virus (EBV) (0.98%, 262 cases), influenza virus (FLU) (0.67%, 181 cases), cytomegalovirus (CMV) (0.53%, 141 cases), candida albicans (C. albicans) (0.48%, 129 cases), and respiratory syncytial virus (RSV) (0.41%, 110 cases) (Table 4). M. pneumoniae was detected more commonly in viral gastroenteritis children infected with RV or NV than with CV or ADV (2.01–2.27% vs. 0–0.57%). EBV (1.00%, 253/25274) and RSV (0.42%, 107/25274) were more commonly co-infected with RV in children with viral gastroenteritis, while CMV more commonly with CV (1.20%, 1/83) and FLU with NV (0.91%, 4/441) (Table 4).
Table 4
Positive number (n) and rate (%) of children hospitalized for viral gastroenteritis with other pathogens
Pathogens
CV (n = 83)
RV (n = 25,274)
NV (n = 441)
ADV (n = 1047)
Total (n = 26,845)
Virus
 EBV
0 (0)
253 (1.00)
4 (0.91)
5 (0.48)
262 (0.98)
 HIV
0 (0)
2 (0.01)
0 (0)
0 (0)
2 (0.01)
 HSV
0 (0)
29 (0.11)
0 (0)
1 (0.10)
30 (0.11)
 RuV
0 (0)
1 (0.004)
0 (0)
0 (0)
1 (0.004)
 PIV
0 (0)
41 (0.16)
4 (0.91)
0 (0)
45 (0.17)
 HV
0 (0)
6 (0.02)
0 (0)
0 (0)
6 (0.02)
 CMV
1 (1.20)
135 (0.53)
3 (0.68)
2 (0.19)
141 (0.53)
 FLU
0 (0)
176 (0.70)
4 (0.91)
1 (0.10)
181 (0.67)
 MV
0 (0)
3 (0.01)
0 (0)
0 (0)
3 (0.01)
 VZV
0 (0)
6 (0.02)
0 (0)
0 (0)
6 (0.02)
 RhV
0 (0)
2 (0.01)
1 (0.23)
0 (0)
3 (0.01)
 RSV
0 (0)
107 (0.42)
1 (0.23)
2 (0.19)
110 (0)
 SARS-CoV-2
0 (0)
2 (0.01)
0 (0)
0 (0)
2 (0.01)
Bacteria
 A. baumannii
0 (0)
1 (0.004)
0 (0)
0 (0)
1 (0.004)
 E. coli
0 (0)
3 (0.01)
0 (0)
0 (0)
3 (0.01)
 S. flexneri
0 (0)
1 (0.004)
0 (0)
0 (0)
1 (0.004)
 S. aureus
0 (0)
2 (0.01)
0 (0)
0 (0)
2 (0.01)
 M. tuberculosis
0 (0)
4 (0.02)
0 (0)
0 (0)
4 (0.01)
 Legionella
0 (0)
26 (0.10)
0 (0)
1 (0.10)
27 (0.10)
 S. pneumoniae
0 (0)
15 (0.06)
1 (0.23)
0 (0)
16 (0.06)
 S. aureus
0 (0)
9 (0.04)
0 (0)
1 (0.10)
10 (0.04)
 Salmonellaa
0 (0)
38 (0.15)
2 (0.45)
6 (0.57)
46 (0.17)
 H. influenzae
0 (0)
15 (0.06)
0 (0)
0 (0)
15 (0.06)
 B. pertussis
0 (0)
6 (0.02)
0 (0)
1 (0.10)
7 (0.03)
 H. pylori
0 (0)
11 (0.04)
0 (0)
0 (0)
11 (0.04)
 Unknown bacteria
0 (0)
32 (0.13)
1 (0.23)
0 (0)
33 (0.12)
Fungi and other pathogens
 C. albicans
0 (0)
119 (0.47)
8 (1.81)
2 (0.19)
129 (0.48)
 Unknown fungi
0 (0)
5 (0.02)
0 (0)
1 (0.10)
6 (0.02)
 A. lumbricoides
0 (0)
7 (0.03)
0 (0)
1 (0.10)
8 (0.03)
 M. pneumoniae
0 (0)
507 (2.01)
10 (2.27)
6 (0.57)
523 (1.95)
 C. pneumoniae
0 (0)
51 (0.20)
0 (0)
0 (0)
51 (0.19)
 TP
0 (0)
1 (0.004)
0 (0)
0 (0)
1 (0.004)
CV Coxsackievirus, RV Rotavirus, NV Norovirus, ADV Adenovirus, EBV Epstein-Barr virus, HIV Human Immunodeficiency Virus, HSV Herpes simplex virus, RuV Rubella virus, PIV Parainfluenza virus, HV Hepatitis virus, CMV Cytomegalovirus, FLU Influenza virus, MV Measles virus, VZV Varicella-zoster virus, RhV Rhinovirus, RSV Respiratory syncytial virus, SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2, A. baumannii: Acinetobacter baumannii, E.coli: Escherichia coli, S. flexneri: Shigella flexneri, S. aureus: Staphylococcus aureus, M. tuberculosis: Mycobacterium tuberculosis, S. pneumoniae: Streptococcus pneumoniae, S. aureus: Staphylococcus aureus, H. influenzae: Haemophilus influenzae, B. pertussis: Bordetella pertussis, H. pylori: Helicobacter pylori, C. albicans: Candida albicans, A. lumbricoides: Ascaris lumbricoides, M. pneumoniae: Mycoplasma pneumoniae, C. pneumoniae: Chlamydia pneumoniae, TP: Treponema pallidum
aThe Salmonella bacteria include Salmonella typhimurium (S. typhimurium), Salmonella Choleraesuis (S. Choleraesuis) and other unclassified strains

Complications

Complications of viral gastroenteritis included dehydration, acidosis, electrolyte disorders and shock (Table 5). Children aged 28 days <  ~  ≤ 1 year were most likely to suffer from acidosis, while those aged 6 <  ~  ≤ 12 years old were most likely to suffer from dehydration (P < 0.001). Dehydration was more common in children with NV infection, while electrolyte disturbances were more prevalent in children with RV infection, and acidosis with ADV infection (P < 0.001).
Table 5
Positive number (n) and rate (%) of children hospitalized for viral gastroenteritis with complications from Jan 1st, 2016 to Dec 31st, 2020
Characteristic
Dehydration (n, %)
Electrolyte disorders (n, %)
Acidosis (n, %)
Shock (n, %)
Total (n, %)
Age group
 ≤ 28 days
101(13.78)a
22(3.00)a
113 (15.42)a
2(0.27)
733
 28 days <  ~  ≤ 1 years old
7491(42.65)b
1944(11.07)b
5726(32.60)b
34(0.19)
17,563
 1 <  ~  ≤ 3 years old
3481 (39.54)c
1191(13.53)c
2388(27.13)c
15(0.17)
8803
 3 <  ~  ≤ 6 years old
326(33.99)d
119(12.41)b,c
226(23.57)d
1 (0.10)
959
 6 <  ~  ≤ 12 years old
26(20.97)e
20(16.13)b,c
13(10.48)a
0(0.00)
124
 > 12 years old
1(14.29)a,b,c,d,e
0(0.00)a,b,c
2(28.57)a,b,c,d
0(0.00)
7
 χ2
292.674
92.778
206.708
1.062
 
 P value
< 0.001
< 0.001
< 0.001
0.975
 
Etiology
 CV
11(13.25)
6(7.23)a,b
3 (3.61)
1(1.20)
83
 RV
10,455(41.37)
3040(12.03)b
7670(30.35)a
43(0.17)
25,274
 NV
226 (51.25)
45(10.20)b
134(30.39)a,b
1 (0.23)
441
 ADV
327(31.23)a
112(10.70)b
359(34.29)b
4(0.38)
1047
 Not clear
407(30.28)a
93(6.92)a
302 (22.47)
3(0.22)
1344
 χ2
150.075
35.962
74.377
7.347
 
 P value
< 0.001
< 0.001
< 0.001
0.119
 
Letters “a” “b” “c” “d” and “e” showed that there was different between groups in the different groups
CV Coxsackievirus, RV Rotavirus, NV Norovirus, ADV Adenovirus

LOS, hospitalization expense, discharge and outcome

The median length of stay (LOS) for hospitalized viral gastroenteritis patients was 5 days (IQR: 3–6 days), and the median expense was 587 USD (541–642 USD) (Table 6). The LOS was shortest for children aged 1 <  ~  ≤ 3 years and longest for children aged 28 days <  ~  ≤ 1 year. Total costs were highest among hospitalized patients aged ≤ 28 days(P < 0.001). Children with RV gastroenteritis had the longest LOS (P < 0.001). The hospital cost was the highest with ADV gastroenteritis (642 US$) and lowest with RV gastroenteritis (541 US$). The majority of hospitalized patients recovered and were able to be discharged within a few days, in which the percentage of discharge by patient with medical advice was 93.5% (26,363 cases) (Table 1). Fortunately, there were no deaths in our study.
Table 6
LOS and hospitalization expense of children with viral gastroenteritis (Median and IQR)
Characteristic
Length of stay (days)
Cost (US dollars)
χ2
P value
Total
5(3–6)
587(541–642)
  
Age group
  
242.05/505.92
< 0.0001
 ≤ 28 days
5(4–7)a
758(555–1035)a
  
 28 days <  ~  ≤ 1 years old
5(4–6)a,b
561(390–778)b
  
 1 <  ~  ≤ 3 years old
5(4–6)c
515(371–703)c
  
 3 <  ~  ≤ 6 years old
4(3–6)d
515(353–695)c
  
 6 <  ~  ≤ 12 years old
4(3–6)c,d
548(365–740)b,c
  
  > 12 years old
6(5–8)a,b,c,d
810(366–1226)a,b,c
  
Regions
  
688.09/2,436.03
< 0.0001
 Northeast
5(4–6)a
566(448–733)a
  
 North China
5(4–6)a
643(477–876)
  
 East China
5(4–6)
473(347–641)
  
 South China
4(3–5)
379(279–536)
  
 Central China
5(4–7)a
442(324–632)
  
 Northwest
5(3–6)
659(450–844)
  
 Southwest
5(4–6)
562(426–736)a
  
Etiology
  
76.76/170.92
< 0.0001
 CV
5(3–6)a,b,c,d,e
541(435–691)a,b,c,d,e
  
 RV
5(4–6)b,d
541(379–751)b
  
 NV
5(4–6)c
627(468–835)a,c,d,e
  
 ADV
5(3–6)d
642(453–835)a,c,d,e
  
 Not clear
4(3–6)e
586(435–811)a,c,d,e
  
Letters “a” “b” “c” “d” and “e” showed that there was different between groups in the different groups
CV Coxsackievirus, RV Rotavirus, NV Norovirus, ADV Adenovirus

Discussion

This study summarized and analyzed the FSMRs data of 28,189 hospitalized children with viral gastroenteritis from 2016 to 2020 in the mainland of China to provide further evidence for the role of gastrointestinal viral infections in this most common gastrointestinal emergency in children. We found that the burden of viral gastroenteritis related hospitalization was the highest among children younger than 3 years of age. RV, CV, ADV and NV accounted for 95.2% of the children with viral gastroenteritis. We demonstrated that the coexistence rates of viral gastroenteritis with upper respiratory tract diseases, myocardial diseases, or seizure were high, and the co-occurrence of other viral, bacterial or atypical pathogen infections was common in pediatric patients hospitalized with viral gastroenteritis, such as M. pneumoniae, EBV and CMV.
Children with viral gastroenteritis under 18 years of age have a ratio of 1.54 to1 between males and females. The result coincided with previous research in China, which showed the ratio was 1.68:1 for children under 5 years of age with gastroenteritis in western China from 2015 to 2019 [14]. Our data suggests that children bearing the greatest burden of hospitalization associated with AGE especially infected with RV were children younger than 3 years (96.3%). In comparison with other studies worldwide [1517], there is a significant difference in the detection rate of rotavirus and norovirus. This may be attributed to the involvement of multiple hospitals in this study, each of which adopted different diagnostic methods. Additionally, RV infection often results in fever, vomiting, dehydration, and severe diarrhea compared to NV infection, increasing the likelihood of hospitalization [1820]. This study specifically focused on hospitalized patients with viral gastroenteritis, rather than the entire population or patients with diarrhea. It’s important to consider that hospitalized patients usually have more severe conditions than outpatients, which may explain the significantly higher detection rate of RV compared to NV. This study clearly showed the seasonal characteristics of the hospitalized cases in children with viral gastroenteritis over the past five years. The fluctuation of the total number and rate were mainly caused by the change in RV, and the infection of rotavirus mainly occurs from November to March, which is in accordance with previous studies from other countries and other regions of China [9, 2123].
In China, the Lanzhou lamb rotavirus (LLR) vaccine was licensed and has been available since 2000 in China, RotaTeq (RV5) in 2018, and Lanzhou lamb reassortant rotavirus vaccine, live, oral, trivalent (Vero cell) (LLR3) in 2023. Even they have not been included in NIPs, the number of rotavirus vaccine doses produced and administered in China has been increasing [24, 25]. RV showed the smallest number and lowest proportion in 2020, which can demonstrate that the contribution of RV to pediatric acute gastroenteritis will gradually decrease as the application of vaccine. Moreover, the COVID-19 (coronavirus disease 2019) pandemic may have altered the epidemiological landscape of various pathogens. In response to COVID-19, control strategies such as social distancing, lockdowns, and enhanced personal hygiene standards were implemented, affecting the transmission of pathogens [2629]. A retrospective study on Chinese Taiwan children revealed that RV hospitalization rates among children < 5 years of age significantly declined by 24.0% in post-vaccine compared to pre-vaccine rotavirus seasons [30]. A multicenter study in China from 2003 to 2012 showed a 70% decrease in the mortality rate of rotavirus gastroenteritis (RVGE) in 2012 compared to 2003 [2]. So, the increasing use of rotavirus vaccines can diminish the burden and change the epidemiology of rotavirus disease worldwide especially in developing countries, as Shim et al. showed that vaccines had a protective effect for hospitalized children with acute gastroenteritis [31]. Advancements in the medical infectious disease reporting system, pathogen detection technology, and awareness about sending specimens for testing for pathogens have resulted in the detection of more positive cases. The first-dose RV vaccine coverage in China was 20.3%, with only 1.8% coverage for the third dose; consequently, despite a decrease in hospitalization and mortality rates for RVGE in China, the disease burden persists [32].
Viral gastroenteritis combined with myocardial diseases refers to the condition where viral infection leads to myocardial damage and myocarditis [33, 34]. In this study, the proportion of viral gastroenteritis combined with myocarditis was high, ranging from 10.98% to 31.04%, in which over 70% of cases were diagnosed with myocardial injuries. Cioc et al. revealed that among 13 cases of sudden cardiac arrest patients, 5 cases of CV and 4 cases of RV in myocardial tissue samples, and a number of case reports have described especially myocarditis of RV infection [35, 36]. Viral gastroenteritis can also be associated with central nervous system (CNS) diseases, known as encephalitis or meningitis. This study found that the proportion of cases with seizures was from 2.41–14.51%, in which benign infantile convulsions had the highest proportion, and benign convulsions with gastroenteritis only accounted for 0–21.88% of cases with seizures, similar to other reports [3739]. There have been numerous cases with respiratory diseases, including 60 cases (6.59%) of ADV-associated pneumonia and bronchopneumonia. According to previous studies, ADV is more commonly cause gastrointestinal diseases by serotypes 40 or 41 [40, 41]. Therefore, for children hospitalized with viral gastroenteritis, we should pay attention to the possibility of concurrent other systemic diseases and remain vigilant for the occurrence of severe cases.
In terms of the co-infection with other pathogens, M. pneumoniae, EBV, FLU, and CMV were the main pathogens of viral gastroenteritis in hospitalized children. M. pneumoniae and FLU infections usually cause respiratory diseases, such as Mycoplasma pneumoniae pneumonia and viral pneumonia, which aligned with the high proportion of respiratory diseases among children with viral gastroenteritis that were mentioned earlier. In this study EBV-positive cases included infectious mononucleosis, EBV viremia, and other EBV-related diseases. It is important to note that a positive result does not necessarily indicate that EBV infection will result in disease or symptoms, because most patients may have latent EBV infection [42]. Similar to EBV, CMV is typically asymptomatic in the majority of individuals. However, in children with compromised immune function who are hospitalized with viral gastroenteritis, CMV infection can cause clinical symptoms and complications, such as hepatitis, pneumonia, and impairment of the brain and visual system. For children with viral gastroenteritis, properly controlling infections caused by other pathogens is crucial to immunocompromised patients, including immune deficiencies, hematopoietic stem cell transplantation or liver transplantation [43, 44].
AGE is generally a self-limiting condition and resolves within one week, which is most commonly associated with viral infection [4547]. There were no fatal cases in our study, as a result of viral gastroenteritis, patients usually suffered from complications, such as dehydration, electrolyte disorders, and acidosis. Our study showed there was more dehydration in children with NV infections, electrolyte disturbances in children with RV infections, and electrolyte disorders with ADV infections. LOS and hospitalization expense of children with viral gastroenteritis were associated with age, region and pathogens in children.
Our study has some limitations. The most frequently seen patients with viral gastroenteritis are outpatients, while our database only contains the data generated from hospitalized children, so little is known regarding the total incidence of viral gastroenteritis. Meanwhile, various detection methods for pathogens in different hospitals lead to the effectiveness of the detection method for the same pathogen is diverse, so we are unable to make comparisons between different pathogens. In this study, no follow-up information was available for the children with viral gastroenteritis, especially patients who had been transferred to other hospitals. Due to a lack of clear information regarding the patient's RV vaccination status, it is hard to assess the protective effect of RV vaccination in viral gastroenteritis.

Conclusion

Rotavirus was detected in nearly 90% of children with viral gastroenteritis among hospitalized children in the mainland of China. Most cases occurred among children younger 3 years during the winter months. Children with viral gastroenteritis were often accompanied by other diseases and pathogens, with myocardial diseases the most common disease and M. pneumoniae the most common pathogen. Continuous surveillance is needed to monitor the prevalence of viral gastroenteritis, and the immunization schedule of rotavirus is essential for adequate management of viral gastroenteritis.

Acknowledgements

We are grateful to investigators from members of the Futang Research Center of Pediatric Development (FRCPD).

Declarations

The study protocol was approved by the medical ethics committee of the Beijing Children’s Hospital, Capital Medical University. The ethics committee approved the waiver of informed consent from parents/guardians of the minors, because the present study was a retrospective analysis of clinical data and all methods were performed in accordance with the ethical guidelines.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Reiner RC Jr, Graetz N, Casey DC, Troeger C, Garcia GM, Mosser JF, et al. Variation in childhood diarrheal morbidity and mortality in Africa, 2000–2015. N Engl J Med. 2018;379(12):1128–38.PubMedCrossRef Reiner RC Jr, Graetz N, Casey DC, Troeger C, Garcia GM, Mosser JF, et al. Variation in childhood diarrheal morbidity and mortality in Africa, 2000–2015. N Engl J Med. 2018;379(12):1128–38.PubMedCrossRef
2.
Zurück zum Zitat Zhang J, Duan Z, Payne DC, Yen C, Pan X, Chang Z, et al. Rotavirus-specific and overall diarrhea mortality in chinese children younger than 5 years: 2003 to 2012. Pediatr Infect Dis J. 2015;34(10):e233–7.PubMedPubMedCentralCrossRef Zhang J, Duan Z, Payne DC, Yen C, Pan X, Chang Z, et al. Rotavirus-specific and overall diarrhea mortality in chinese children younger than 5 years: 2003 to 2012. Pediatr Infect Dis J. 2015;34(10):e233–7.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Meier JL. Viral acute gastroenteritis in special populations. Gastroenterol Clin North Am. 2021;50(2):305–22.PubMedCrossRef Meier JL. Viral acute gastroenteritis in special populations. Gastroenterol Clin North Am. 2021;50(2):305–22.PubMedCrossRef
4.
Zurück zum Zitat Hartman S, Brown E, Loomis E, Russell HA. Gastroenteritis in children. Am Fam Physician. 2019;99(3):159–65.PubMed Hartman S, Brown E, Loomis E, Russell HA. Gastroenteritis in children. Am Fam Physician. 2019;99(3):159–65.PubMed
5.
Zurück zum Zitat Collaborators GDaI. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18(11):1211–28.CrossRef Collaborators GDaI. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18(11):1211–28.CrossRef
6.
Zurück zum Zitat Yang L, Shi S, Na C, Li B, Zhao Z, Yang T, et al. Rotavirus and norovirus infections in children under 5 years old with acute gastroenteritis in Southwestern China, 2018–2020. J Epidemiol Glob Health. 2022;12(3):292–303.PubMedPubMedCentralCrossRef Yang L, Shi S, Na C, Li B, Zhao Z, Yang T, et al. Rotavirus and norovirus infections in children under 5 years old with acute gastroenteritis in Southwestern China, 2018–2020. J Epidemiol Glob Health. 2022;12(3):292–303.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Pitkänen O, Markkula J, Hemming-Harlo M. A major decrease in viral acute gastroenteritis in hospitalized finnish children as rotavirus returns as the most detected pathogen. Int J Infect Dis. 2022;114:273–8.PubMedCrossRef Pitkänen O, Markkula J, Hemming-Harlo M. A major decrease in viral acute gastroenteritis in hospitalized finnish children as rotavirus returns as the most detected pathogen. Int J Infect Dis. 2022;114:273–8.PubMedCrossRef
8.
Zurück zum Zitat Öner SZ, Kaleli İ, Demi RM, Mete E, Çalişkan A. Rotavirus and adenovirus prevalence in patients with acute viral gastroenteritis in Denizli, Turkey, 2017–2021. J Med Virol. 2022;94(8):3857–62.PubMedCrossRef Öner SZ, Kaleli İ, Demi RM, Mete E, Çalişkan A. Rotavirus and adenovirus prevalence in patients with acute viral gastroenteritis in Denizli, Turkey, 2017–2021. J Med Virol. 2022;94(8):3857–62.PubMedCrossRef
9.
Zurück zum Zitat Paternina-Caicedo A, Parashar U, Garcia-Calavaro C, de Oliveira LH, Alvis-Guzman N, De la Hoz-Restrepo F. Diarrheal deaths after the introduction of rotavirus vaccination in 4 countries. Pediatrics. 2021;147(1):e20193167.PubMedCrossRef Paternina-Caicedo A, Parashar U, Garcia-Calavaro C, de Oliveira LH, Alvis-Guzman N, De la Hoz-Restrepo F. Diarrheal deaths after the introduction of rotavirus vaccination in 4 countries. Pediatrics. 2021;147(1):e20193167.PubMedCrossRef
10.
Zurück zum Zitat Burke RM, Tate JE, Han GS, Quenelle R, Gautam R, Wadford DA, et al. Rotavirus vaccination coverage during a rotavirus outbreak resulting in a fatality at a subacute care facility. J Pediatric Infect Dis Soc. 2020;9(3):287–92.PubMedCrossRef Burke RM, Tate JE, Han GS, Quenelle R, Gautam R, Wadford DA, et al. Rotavirus vaccination coverage during a rotavirus outbreak resulting in a fatality at a subacute care facility. J Pediatric Infect Dis Soc. 2020;9(3):287–92.PubMedCrossRef
11.
Zurück zum Zitat Hallowell BD, Parashar UD, Curns A, DeGroote NP, Tate JE. Trends in the laboratory detection of rotavirus before and after implementation of routine rotavirus vaccination - United States, 2000–2018. MMWR Morb Mortal Wkly Rep. 2019;68(24):539–43.PubMedPubMedCentralCrossRef Hallowell BD, Parashar UD, Curns A, DeGroote NP, Tate JE. Trends in the laboratory detection of rotavirus before and after implementation of routine rotavirus vaccination - United States, 2000–2018. MMWR Morb Mortal Wkly Rep. 2019;68(24):539–43.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Feng G, Zeng Y, Tian J, Wang X, Tai J, Song F, et al. Disease spectrum analysis of hospitalized children in China: a study of 18 tertiary children’s hospitals. Pediatr Investig. 2019;3(3):159–64.PubMedPubMedCentralCrossRef Feng G, Zeng Y, Tian J, Wang X, Tai J, Song F, et al. Disease spectrum analysis of hospitalized children in China: a study of 18 tertiary children’s hospitals. Pediatr Investig. 2019;3(3):159–64.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Guo K, Wang XY, Feng GS, Tian J, Zeng YP, Ma SX, et al. The epidemiology of blood transfusion in hospitalized children: a national cross-sectional study in China. Transl Pediatr. 2021;10(4):1055–62.PubMedPubMedCentralCrossRef Guo K, Wang XY, Feng GS, Tian J, Zeng YP, Ma SX, et al. The epidemiology of blood transfusion in hospitalized children: a national cross-sectional study in China. Transl Pediatr. 2021;10(4):1055–62.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Cao RR, Ma XZ, Li WY, Wang BN, Yang Y, Wang HR, et al. Epidemiology of norovirus gastroenteritis in hospitalized children under five years old in western China, 2015–2019. J Microbiol Immunol Infect. 2021;54(5):918–25.PubMedCrossRef Cao RR, Ma XZ, Li WY, Wang BN, Yang Y, Wang HR, et al. Epidemiology of norovirus gastroenteritis in hospitalized children under five years old in western China, 2015–2019. J Microbiol Immunol Infect. 2021;54(5):918–25.PubMedCrossRef
15.
Zurück zum Zitat Amodio E, De Grazia S, Genovese D, Bonura F, Filizzolo C, Collura A, et al. Clinical and epidemiologic features of viral gastroenteritis in hospitalized children: an 11-year surveillance in palermo (Sicily). Viruses. 2022;15(1):41.PubMedPubMedCentralCrossRef Amodio E, De Grazia S, Genovese D, Bonura F, Filizzolo C, Collura A, et al. Clinical and epidemiologic features of viral gastroenteritis in hospitalized children: an 11-year surveillance in palermo (Sicily). Viruses. 2022;15(1):41.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Calduch EN, Cattaert T, Verstraeten T. Model estimates of hospitalization discharge rates for norovirus gastroenteritis in Europe, 2004–2015. BMC Infect Dis. 2021;21(1):757.PubMedPubMedCentralCrossRef Calduch EN, Cattaert T, Verstraeten T. Model estimates of hospitalization discharge rates for norovirus gastroenteritis in Europe, 2004–2015. BMC Infect Dis. 2021;21(1):757.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Aliabadi N, Antoni S, Mwenda JM, Weldegebriel G, Biey JNM, Cheikh D, et al. Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008–16: findings from the global rotavirus surveillance network. Lancet Glob Health. 2019;7(7):e893–903.PubMedPubMedCentralCrossRef Aliabadi N, Antoni S, Mwenda JM, Weldegebriel G, Biey JNM, Cheikh D, et al. Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008–16: findings from the global rotavirus surveillance network. Lancet Glob Health. 2019;7(7):e893–903.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Zhang J, Yang F. Correlation between infection with rotavirus and norovirus and acute gastroenteritis in children. Endemic Dis Bull (in Chinese). 2018;33(03):74–6. Zhang J, Yang F. Correlation between infection with rotavirus and norovirus and acute gastroenteritis in children. Endemic Dis Bull (in Chinese). 2018;33(03):74–6.
19.
Zurück zum Zitat Cui X, Feng G, Jln F, Xu X. Investigation and clinical analysis of norovirus and rotavirus infection in 942 children with acute diarrhea. Chin J Practical Pediatr (in Chinese). 2016;31(08):603–7. Cui X, Feng G, Jln F, Xu X. Investigation and clinical analysis of norovirus and rotavirus infection in 942 children with acute diarrhea. Chin J Practical Pediatr (in Chinese). 2016;31(08):603–7.
20.
Zurück zum Zitat Wei K, Liu X, Liu D, Chang Q, Xiang J, Wang P. Investigation on the prevalence of group A rotavirus and norovirus in hospitalized children with diarrhea in Wuwei area, Gansu province. Chin J Viral Dis (in Chinese). 2014;4(02):137–40. Wei K, Liu X, Liu D, Chang Q, Xiang J, Wang P. Investigation on the prevalence of group A rotavirus and norovirus in hospitalized children with diarrhea in Wuwei area, Gansu province. Chin J Viral Dis (in Chinese). 2014;4(02):137–40.
21.
Zurück zum Zitat Sharma P, Katewa S, Meel SK, Katewa V, Bishnoi A, Verma VK, et al. Clinicoepidemiological profile and genetic characterization of circulating rotavirus strain among children < 5 years hospitalized for acute gastroenteritis in Western Rajasthan. India Indian J Pediatr. 2021;88(Suppl 1):97–104.PubMedCrossRef Sharma P, Katewa S, Meel SK, Katewa V, Bishnoi A, Verma VK, et al. Clinicoepidemiological profile and genetic characterization of circulating rotavirus strain among children < 5 years hospitalized for acute gastroenteritis in Western Rajasthan. India Indian J Pediatr. 2021;88(Suppl 1):97–104.PubMedCrossRef
22.
Zurück zum Zitat Lu W, Li J, Li J, Ai D, Song H, Duan Z, et al. Short-term impacts of meteorology, air pollution, and internet search data on viral diarrhea infection among children in Jilin Province, China. Int J Environ Res Public Health. 2021;18(21):11615.PubMedPubMedCentralCrossRef Lu W, Li J, Li J, Ai D, Song H, Duan Z, et al. Short-term impacts of meteorology, air pollution, and internet search data on viral diarrhea infection among children in Jilin Province, China. Int J Environ Res Public Health. 2021;18(21):11615.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Nan X, Jinyuan W, Yan Z, Maosheng S, Hongjun L. Epidemiological and clinical studies of rotavirus-induced diarrhea in China from 1994–2013. Hum Vaccin Immunother. 2014;10(12):3672–80.PubMedCrossRef Nan X, Jinyuan W, Yan Z, Maosheng S, Hongjun L. Epidemiological and clinical studies of rotavirus-induced diarrhea in China from 1994–2013. Hum Vaccin Immunother. 2014;10(12):3672–80.PubMedCrossRef
24.
Zurück zum Zitat Fu C, Dong Z, Shen J, Yang Z, Liao Y, Hu W, et al. Rotavirus gastroenteritis infection among children vaccinated and unvaccinated with rotavirus vaccine in Southern China: a population-based assessment. JAMA Netw Open. 2018;1(4):e181382.PubMedPubMedCentralCrossRef Fu C, Dong Z, Shen J, Yang Z, Liao Y, Hu W, et al. Rotavirus gastroenteritis infection among children vaccinated and unvaccinated with rotavirus vaccine in Southern China: a population-based assessment. JAMA Netw Open. 2018;1(4):e181382.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Zhang H, Lai X, Mak J, Sriudomporn S, Zhang H, Fang H, et al. Coverage and equity of childhood vaccines in China. JAMA Netw Open. 2022;5(12):e2246005.PubMedPubMedCentralCrossRef Zhang H, Lai X, Mak J, Sriudomporn S, Zhang H, Fang H, et al. Coverage and equity of childhood vaccines in China. JAMA Netw Open. 2022;5(12):e2246005.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Steens A, Knol MJ, Freudenburg-de Graaf W, de Melker HE, van der Ende A, van Sorge NM. Pathogen- and type-specific changes in invasive bacterial disease epidemiology during the first year of the COVID-19 pandemic in The Netherlands. Microorganisms. 2022;10(5):972.PubMedPubMedCentralCrossRef Steens A, Knol MJ, Freudenburg-de Graaf W, de Melker HE, van der Ende A, van Sorge NM. Pathogen- and type-specific changes in invasive bacterial disease epidemiology during the first year of the COVID-19 pandemic in The Netherlands. Microorganisms. 2022;10(5):972.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Lamrani Hanchi A, Guennouni M, Ben Houmich T, Echchakery M, Draiss G, Rada N, et al. Changes in the epidemiology of respiratory pathogens in children during the COVID-19 pandemic. Pathogens. 2022;11(12):1542.PubMedPubMedCentralCrossRef Lamrani Hanchi A, Guennouni M, Ben Houmich T, Echchakery M, Draiss G, Rada N, et al. Changes in the epidemiology of respiratory pathogens in children during the COVID-19 pandemic. Pathogens. 2022;11(12):1542.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Luciani L, Ninove L, Zandotti C, Nougairède A. COVID-19 pandemic and its consequences disrupt epidemiology of enterovirus meningitis. South-East France J Med Virol. 2021;93(4):1929–31.PubMedCrossRef Luciani L, Ninove L, Zandotti C, Nougairède A. COVID-19 pandemic and its consequences disrupt epidemiology of enterovirus meningitis. South-East France J Med Virol. 2021;93(4):1929–31.PubMedCrossRef
29.
Zurück zum Zitat Kies KD, Thomas AS, Binnicker MJ, Bashynski KL, Patel R. Decrease in enteroviral meningitis: an unexpected benefit of coronavirus disease 2019 (COVID-19) mitigation? Clin Infect Dis. 2021;73(9):e2807–9.PubMedCrossRef Kies KD, Thomas AS, Binnicker MJ, Bashynski KL, Patel R. Decrease in enteroviral meningitis: an unexpected benefit of coronavirus disease 2019 (COVID-19) mitigation? Clin Infect Dis. 2021;73(9):e2807–9.PubMedCrossRef
30.
Zurück zum Zitat Burke RM, Shih S, Hsiung CA, Yen C, Jiang B, Parashar UD, et al. Impact of rotavirus vaccination on rotavirus hospitalizations in Taiwanese children. Vaccine. 2021;39(49):7135–9.PubMedPubMedCentralCrossRef Burke RM, Shih S, Hsiung CA, Yen C, Jiang B, Parashar UD, et al. Impact of rotavirus vaccination on rotavirus hospitalizations in Taiwanese children. Vaccine. 2021;39(49):7135–9.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Shim JO, Chang JY, Shin S, Moon JS, Ko JS. Changing distribution of age, clinical severity, and genotypes of rotavirus gastroenteritis in hospitalized children after the introduction of vaccination: a single center study in Seoul between 2011 and 2014. BMC Infect Dis. 2016;16:287.PubMedPubMedCentralCrossRef Shim JO, Chang JY, Shin S, Moon JS, Ko JS. Changing distribution of age, clinical severity, and genotypes of rotavirus gastroenteritis in hospitalized children after the introduction of vaccination: a single center study in Seoul between 2011 and 2014. BMC Infect Dis. 2016;16:287.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Luo HM, Ran L, Meng L, Lian YY, Wang LP. Analysis of epidemiological characteristics of report cases of rotavirus diarrhea in children under 5 years old in China, 2005–2018. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(2):181–6.PubMed Luo HM, Ran L, Meng L, Lian YY, Wang LP. Analysis of epidemiological characteristics of report cases of rotavirus diarrhea in children under 5 years old in China, 2005–2018. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(2):181–6.PubMed
33.
Zurück zum Zitat Rauff B, Malik A, Bhatti YA, Chudhary SA, Fatima K, Rafiq S, et al. Association of viruses in the development of cardiovascular diseases. Curr Pharm Des. 2021;27(37):3913–23.PubMedCrossRef Rauff B, Malik A, Bhatti YA, Chudhary SA, Fatima K, Rafiq S, et al. Association of viruses in the development of cardiovascular diseases. Curr Pharm Des. 2021;27(37):3913–23.PubMedCrossRef
34.
Zurück zum Zitat Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020;13(11):e007405.PubMedPubMedCentralCrossRef Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020;13(11):e007405.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Dian Z, Sun Y, Zhang G, Xu Y, Fan X, Yang X, et al. Rotavirus-related systemic diseases: clinical manifestation, evidence and pathogenesis. Crit Rev Microbiol. 2021;47(5):580–95.PubMedCrossRef Dian Z, Sun Y, Zhang G, Xu Y, Fan X, Yang X, et al. Rotavirus-related systemic diseases: clinical manifestation, evidence and pathogenesis. Crit Rev Microbiol. 2021;47(5):580–95.PubMedCrossRef
36.
Zurück zum Zitat Cioc AM, Nuovo GJ. Histologic and in situ viral findings in the myocardium in cases of sudden, unexpected death. Mod Pathol. 2002;15(9):914–22.PubMedCrossRef Cioc AM, Nuovo GJ. Histologic and in situ viral findings in the myocardium in cases of sudden, unexpected death. Mod Pathol. 2002;15(9):914–22.PubMedCrossRef
37.
Zurück zum Zitat Ogawa C, Kidokoro H, Ishihara N, Tsuji T, Kurahashi H, Hattori A, et al. Splenial lesions in benign convulsions with gastroenteritis associated with rotavirus infection. Pediatr Neurol. 2020;109:79–84.PubMedCrossRef Ogawa C, Kidokoro H, Ishihara N, Tsuji T, Kurahashi H, Hattori A, et al. Splenial lesions in benign convulsions with gastroenteritis associated with rotavirus infection. Pediatr Neurol. 2020;109:79–84.PubMedCrossRef
38.
Zurück zum Zitat Wang D, Jiang Y, Hong S, Ma J, Liao S, Cheng M, et al. Prognostic factors for the recurrence of afebrile seizures after benign convulsions associated with mild gastroenteritis. Epilepsia. 2021;62(12):3068–75.PubMedCrossRef Wang D, Jiang Y, Hong S, Ma J, Liao S, Cheng M, et al. Prognostic factors for the recurrence of afebrile seizures after benign convulsions associated with mild gastroenteritis. Epilepsia. 2021;62(12):3068–75.PubMedCrossRef
39.
Zurück zum Zitat Hungerford DJ, French N, Iturriza-Gómara M, Read JM, Cunliffe NA, Vivancos R. Reduction in hospitalisations for acute gastroenteritis-associated childhood seizures since introduction of rotavirus vaccination: a time-series and change-point analysis of hospital admissions in England. J Epidemiol Community Health. 2019;73(11):1020–5.PubMedCrossRef Hungerford DJ, French N, Iturriza-Gómara M, Read JM, Cunliffe NA, Vivancos R. Reduction in hospitalisations for acute gastroenteritis-associated childhood seizures since introduction of rotavirus vaccination: a time-series and change-point analysis of hospital admissions in England. J Epidemiol Community Health. 2019;73(11):1020–5.PubMedCrossRef
40.
Zurück zum Zitat Sdiri-Loulizi K, Gharbi-Khelifi H, de Rougemont A, Hassine M, Chouchane S, Sakly N, et al. Molecular epidemiology of human astrovirus and adenovirus serotypes 40/41 strains related to acute diarrhea in Tunisian children. J Med Virol. 2009;81(11):1895–902.PubMedCrossRef Sdiri-Loulizi K, Gharbi-Khelifi H, de Rougemont A, Hassine M, Chouchane S, Sakly N, et al. Molecular epidemiology of human astrovirus and adenovirus serotypes 40/41 strains related to acute diarrhea in Tunisian children. J Med Virol. 2009;81(11):1895–902.PubMedCrossRef
41.
Zurück zum Zitat Dey RS, Ghosh S, Chawla-Sarkar M, Panchalingam S, Nataro JP, Sur D, et al. Circulation of a novel pattern of infections by enteric adenovirus serotype 41 among children below 5 years of age in Kolkata. India J Clin Microbiol. 2011;49(2):500–5.PubMedCrossRef Dey RS, Ghosh S, Chawla-Sarkar M, Panchalingam S, Nataro JP, Sur D, et al. Circulation of a novel pattern of infections by enteric adenovirus serotype 41 among children below 5 years of age in Kolkata. India J Clin Microbiol. 2011;49(2):500–5.PubMedCrossRef
43.
Zurück zum Zitat Kohli R, Cortes M, Heaton ND, Dhawan A. Liver transplantation in children: state of the art and future perspectives. Arch Dis Child. 2018;103(2):192–8.PubMedCrossRef Kohli R, Cortes M, Heaton ND, Dhawan A. Liver transplantation in children: state of the art and future perspectives. Arch Dis Child. 2018;103(2):192–8.PubMedCrossRef
44.
Zurück zum Zitat Bateman CM, Kesson A, Powys M, Wong M, Blyth E. Cytomegalovirus Infections in children with primary and secondary immune deficiencies. Viruses. 2021;13(10):2001.PubMedPubMedCentralCrossRef Bateman CM, Kesson A, Powys M, Wong M, Blyth E. Cytomegalovirus Infections in children with primary and secondary immune deficiencies. Viruses. 2021;13(10):2001.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Posovszky C, Buderus S, Classen M, Lawrenz B, Keller KM, Koletzko S. Acute infectious gastroenteritis in infancy and childhood. Dtsch Arztebl Int. 2020;117(37):615–24.PubMedPubMedCentral Posovszky C, Buderus S, Classen M, Lawrenz B, Keller KM, Koletzko S. Acute infectious gastroenteritis in infancy and childhood. Dtsch Arztebl Int. 2020;117(37):615–24.PubMedPubMedCentral
46.
Zurück zum Zitat Lee B, Damon CF, Platts-Mills JA. Pediatric acute gastroenteritis associated with adenovirus 40/41 in low-income and middle-income countries. Curr Opin Infect Dis. 2020;33(5):398–403.PubMedPubMedCentralCrossRef Lee B, Damon CF, Platts-Mills JA. Pediatric acute gastroenteritis associated with adenovirus 40/41 in low-income and middle-income countries. Curr Opin Infect Dis. 2020;33(5):398–403.PubMedPubMedCentralCrossRef
Metadaten
Titel
Changes in the epidemiology and clinical characteristics of viral gastroenteritis among hospitalized children in the Mainland of China: a retrospective study from 2016 to 2020
verfasst von
Fei Li
Lingyun Guo
Qi Li
Hui Xu
Yiliang Fu
Luci Huang
Guoshuang Feng
Gang Liu
Xiangpeng Chen
Zhengde Xie
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Pediatrics / Ausgabe 1/2024
Elektronische ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-024-04776-1

Weitere Artikel der Ausgabe 1/2024

BMC Pediatrics 1/2024 Zur Ausgabe

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.